Insider Trading Activity Spark Therapeutics, Inc. (NASDAQ:ONCE) – CEO Sold 28,650 shares of Stock

ME Staff
-
0

Insider Trading Activity For Spark Therapeutics, Inc. (NASDAQ:ONCE)

Jeffrey D Marrazzo , CEO of Spark Therapeutics, Inc. (NASDAQ:ONCE) reportedly Sold 28,650 shares of the company’s stock at an average price of 80.01 for a total transaction amount of $2,292,286.50 SEC Form

Insider Trading History For Spark Therapeutics, Inc. (NASDAQ:ONCE)

  • On 2/4/2015 Stephen W Webster, CFO, bought 2,500 with an average share price of $23.00 per share and the total transaction amounting to $57,500.00.View SEC Filing
  • On 2/4/2015 Hospital Of Philade Children’s, Major Shareholder, bought 100,000 with an average share price of $23.00 per share and the total transaction amounting to $2,300,000.00.View SEC Filing
  • On 2/4/2015 Anand Mehra, Director, bought 225,000 with an average share price of $23.00 per share and the total transaction amounting to $5,175,000.00.View SEC Filing
  • On 10/7/2015 Steven Altschuler, Director, bought 5,000 with an average share price of $49.11 per share and the total transaction amounting to $245,550.00.View SEC Filing
  • On 10/7/2015 Stephen W. Webster, CFO, sold 20,000 with an average share price of $48.86 per share and the total transaction amounting to $977,200.00.View SEC Filing
  • On 10/7/2015 Coelho Rogerio Vivaldi, insider, sold 41,000 with an average share price of $48.85 per share and the total transaction amounting to $2,002,850.00.View SEC Filing
  • On 10/8/2015 Anand Mehra, Director, sold 529,544 with an average share price of $45.46 per share and the total transaction amounting to $24,073,070.24.View SEC Filing

    • Analyst Ratings For Spark Therapeutics, Inc. (NASDAQ:ONCE)
    These are 1 Sell Rating, 10 Buy Ratings .
    The current consensus rating for Spark Therapeutics, Inc. (NASDAQ:ONCE) is Buy (Score: 2.82) with a consensus target price of $84.70 , a potential (10.06% upside)

    Analyst Ratings History For Spark Therapeutics, Inc. (NASDAQ:ONCE)

    • On 10/11/2015 Roth Capital Reiterated Rating Buy
    • On 12/24/2015 Wunderlich Downgraded rating Buy to Hold
    • On 3/30/2016 Goldman Sachs Group, Inc. (The) Initiated Coverage of rating Buy to Neutral with a price target of $44.00
    • On 4/12/2016 Evercore ISI Initiated Coverage of rating Buy with a price target of $37.00
    • On 6/21/2016 SunTrust Banks, Inc. Boost Price Target of rating Buy with a price target of $64.00 to $72.00
    • On 7/12/2016 Royal Bank Of Canada Initiated Coverage of rating Outperform with a price target of $70.00
    • On 2/9/2017 Leerink Swann Initiated Coverage of rating Outperform to Outperform with a price target of $85.00

    Recent Trading Activity for Spark Therapeutics, Inc. (NASDAQ:ONCE)
    Shares of Spark Therapeutics, Inc. closed the previous trading session at 76.96 up +0.11 0.14% with 1,068,000 shares trading hands.